Literature DB >> 33622379

Increased ribosomal protein levels and protein synthesis in the striatal synaptosome of Shank3-overexpressing transgenic mice.

Chunmei Jin1,2, Yeunkum Lee1,2, Hyojin Kang3, Kwon Jeong4,5, Joori Park4,5, Yinhua Zhang1,2, Hyae Rim Kang1,2, Ruiying Ma1,2, Hyunyoung Seong1, Yoonhee Kim1, Hosung Jung6,7, Jin Young Kim8, Yoon Ki Kim4,5, Kihoon Han9,10.   

Abstract

The SH3 and multiple ankyrin repeat domains 3 (Shank3) protein is a core organizer of the macromolecular complex in excitatory postsynapses, and its defects cause numerous synaptopathies, including autism spectrum disorders. Although the function of Shank3 as a postsynaptic scaffold is adequately established, other potential mechanisms through which Shank3 broadly modulates the postsynaptic proteome remain relatively unexplored. In our previous quantitative proteomic analysis, six up-regulated ribosomal proteins were identified in the striatal synaptosome of Shank3-overexpressing transgenic (TG) mice. In the present study, we validated the increased levels of RPLP1 and RPL36A in synaptosome, but not in whole lysate, of the TG striatum. Moreover, protein synthesis and extracellular signaling-regulated kinase (ERK) activity were enhanced in the TG striatal synaptosome. To understand the potential contribution of increased protein synthesis to the proteomic change in the TG striatal synaptosome, we performed RNA-sequencing analyses on both whole synaptosomal and synaptic polysome-enriched fractions. Comparative analyses showed a positive correlation only between the polysome-associated transcriptome and up-regulated proteome in the TG striatal synaptosome. Our findings suggest a novel mechanism through which Shank3 may remodel the postsynaptic proteome by regulating synaptic protein synthesis, whose dysfunction can be implicated in SHANK3-associated synaptopathies.

Entities:  

Keywords:  Protein synthesis; Ribosomal protein; Shank3; Striatum; Synaptosome

Year:  2021        PMID: 33622379     DOI: 10.1186/s13041-021-00756-z

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


  16 in total

Review 1.  Protein homeostasis and synaptic plasticity.

Authors:  Iván J Cajigas; Tristan Will; Erin M Schuman
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

2.  Shank3 regulates striatal synaptic abundance of Cyld, a deubiquitinase specific for Lys63-linked polyubiquitin chains.

Authors:  Chunmei Jin; Shinhyun Kim; Hyojin Kang; Ki Na Yun; Yeunkum Lee; Yinhua Zhang; Yoonhee Kim; Jin Young Kim; Kihoon Han
Journal:  J Neurochem       Date:  2019-07-11       Impact factor: 5.372

3.  The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging.

Authors:  Iván J Cajigas; Georgi Tushev; Tristan J Will; Susanne tom Dieck; Nicole Fuerst; Erin M Schuman
Journal:  Neuron       Date:  2012-05-10       Impact factor: 17.173

Review 4.  The Shank family of scaffold proteins.

Authors:  M Sheng; E Kim
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

5.  Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling.

Authors:  Yeunkum Lee; Sun Gyun Kim; Bokyoung Lee; Yinhua Zhang; Yoonhee Kim; Shinhyun Kim; Eunjoon Kim; Hyojin Kang; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2017-06-28       Impact factor: 5.639

6.  Integrative Brain Transcriptome Analysis Reveals Region-Specific and Broad Molecular Changes in Shank3-Overexpressing Mice.

Authors:  Chunmei Jin; Hyojin Kang; Jae Ryun Ryu; Shinhyun Kim; Yinhua Zhang; Yeunkum Lee; Yoonhee Kim; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2018-08-31       Impact factor: 5.639

7.  An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function.

Authors:  Li Wang; Kaifang Pang; Kihoon Han; Carolyn J Adamski; Wei Wang; Lingjie He; Jason K Lai; Vitaliy V Bondar; Joseph G Duman; Ronald Richman; Kimberley F Tolias; Patrick Barth; Timothy Palzkill; Zhandong Liu; J Lloyd Holder; Huda Y Zoghbi
Journal:  Mol Psychiatry       Date:  2019-01-04       Impact factor: 15.992

8.  SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties.

Authors:  Kihoon Han; J Lloyd Holder; Christian P Schaaf; Hui Lu; Hongmei Chen; Hyojin Kang; Jianrong Tang; Zhenyu Wu; Shuang Hao; Sau Wai Cheung; Peng Yu; Hao Sun; Amy M Breman; Ankita Patel; Hui-Chen Lu; Huda Y Zoghbi
Journal:  Nature       Date:  2013-10-23       Impact factor: 49.962

9.  Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism.

Authors:  Eleonora Rosina; Barbara Battan; Martina Siracusano; Lorena Di Criscio; Fiona Hollis; Laura Pacini; Paolo Curatolo; Claudia Bagni
Journal:  Transl Psychiatry       Date:  2019-01-31       Impact factor: 6.222

10.  Editorial: Shankopathies: Shank Protein Deficiency-Induced Synaptic Diseases.

Authors:  Elodie Ey; Thomas Bourgeron; Tobias M Boeckers; Eunjoon Kim; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2020-02-07       Impact factor: 5.639

View more
  4 in total

Review 1.  Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.

Authors:  Jan Philipp Delling; Tobias M Boeckers
Journal:  J Neurodev Disord       Date:  2021-11-16       Impact factor: 4.025

2.  Neuroligins in neurodevelopmental conditions: how mouse models of de novo mutations can help us link synaptic function to social behavior.

Authors:  Tobias T Pohl; Hanna Hörnberg
Journal:  Neuronal Signal       Date:  2022-05-10

Review 3.  Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesions.

Authors:  Xiu-Quan Wu; Ning Su; Zhou Fei; Fei Fei
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

4.  Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder.

Authors:  Noor B Almandil; Abdulla AlSulaiman; Sumayh A Aldakeel; Deem N Alkuroud; Halah Egal Aljofi; Safah Alzahrani; Aishah Al-Mana; Asma A Alfuraih; Majed Alabdali; Fahd A Alkhamis; Sayed AbdulAzeez; J Francis Borgio
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.